The hypercholesterolemia PCSK9 mutations were all missense variants that are thought to confer a gain of function as overexpression of pcsk9 in the liver of mice produces hypercholesterolemia by reducing LDLR numbers (Lambert et al., 2006). This evidence concerns the gene PCSK9 and Hypercholesterolemia.